Health care stocks were lower late Monday afternoon, with the NYSE Health Care Index down 0.3% and the Health Care Select Sector SPDR Fund (XLV) easing 0.1%.
The iShares Biotechnology ETF (IBB) added 0.1%.
In corporate news, Predictive Oncology (POAI) shares surged past 55% after it agreed to be acquired by Renovaro (RENB) in an all-stock deal. Renovaro shares popped 10%.
Citius Pharmaceuticals' (CTXR) majority-owned subsidiary Citius Oncology (CTOR) said it has retained Jefferies as a financial advisor to evaluate possible strategic alternatives. Citius Pharmaceuticals shares were down 2.3% and Citius Oncology jumped 18%.
Revance Therapeutics (RVNC) shares jumped 12%. The company has received a new buyout proposal from Teoxane Laboratories, offering $3.60 per share in cash, topping a bid from Crown Laboratories of $3.10 per share.
Regional Health Properties (RHE) and SunLink Health Systems (SSY) have agreed to merge in an all-stock deal. Regional shares soared 120% and SunLink surged 16%.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。